Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.220
-0.020 (-0.47%)
Feb 17, 2026, 3:10 PM EST - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $539.59 million as of February 17, 2026. Its market cap has decreased by -25.99% in one year.
Market Cap
539.59M
Enterprise Value
307.80M
1-Year Change
-25.99%
Ranking
Category
Stock Price
$4.22
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $539.59M, a decrease of -76.13%. That is a compound annual growth rate of -26.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 542.15M | -16.04% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 665.19M |
| Beta Bionics | 613.70M |
| Tactile Systems Technology | 590.78M |
| Varex Imaging | 566.75M |
| Bioventus | 553.90M |
| Perspective Therapeutics | 535.40M |
| Orthofix Medical | 529.84M |
| Pacific Biosciences of California | 516.26M |